Response and safety of whole‐brain radiotherapy plus temozolomide for patients with brain metastases of non‐small‐cell lung cancer: A meta‐analysis
Abstract Objective The aim of the present work was to investigate the response and safety of whole‐brain radiotherapy (WBRT) plus temozolomide (TMZ) for patients with brain metastases of non‐small‐cell lung cancer (NSCLC). Methods The electronic databases of Pubmed, EMbase, Cochrane, Wangfang, china...
Guardado en:
Autores principales: | Jianguo Han, Ming Qiu, Li Su, Chong Wu, Si Cheng, Zhijun Zhao, Danxia Li, Menghui Wang, Wei Tao, Shiwei Du |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0bd643f7339348b8bdf053692a1cb7e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reirradiation of Whole Brain for Recurrent Brain Metastases: A Case Report of Lung Cancer With 12-Year Survival
por: Minmin Li, et al.
Publicado: (2021) -
Intraoperative Radiotherapy in Brain Malignancies: Indications and Outcomes in Primary and Metastatic Brain Tumors
por: Christopher P. Cifarelli, et al.
Publicado: (2021) -
Predictive effect of DCE-MRI and DWI in brain metastases from NSCLC
por: Ye Chengyu, et al.
Publicado: (2021) -
Clinicopathological characteristics and prognosis of brain metastases in elderly patients with esophageal carcinoma
por: Yi Wang, et al.
Publicado: (2021) -
Novel prognostic classification predicts overall survival of patients receiving salvage whole-brain radiotherapy for recurrent brain metastasis from breast cancer: A recursive partitioning analysis (KROG 16-12)
por: Jae Sik Kim, et al.
Publicado: (2021)